HNRNPA2B1 and glioblastoma: For example, in breast cancer, knocking down hnRNPA2B1 leads to apoptosis of tumor cells, so hnRNPA2B1 is an oncogene in glioblastoma development and therefore may serve as a predictor of glioblastoma patient survival [41, 42].